Long-term safety and efficacy of intramyocardial adenovirus-mediated VEGF-DdNdC gene therapy: eight-year follow-up of phase 1 KAT301 study
Event:
ESC Congress 2021 - The Digital Experience
Topic:
Gene Therapy, Cell Therapy
Session:
Basic science e-posters
